Related Experiment Video
Updated: Jan 15, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
lnc-MPEG1-1 promotes papillary thyroid carcinoma progression through association with BRAF mutations
Xing Liu1, Wenjing Yang1, Rongfang Shen1
1Department of Thyroid and Neck Surgery, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
Introduction:
Papillary thyroid carcinoma (PTC) is the most common endocrine malignancy, with rising incidence in recent years. Long non-coding RNAs (lncRNAs) have been implicated in various cancers, including PTC. This study aims to identify novel lncRNA biomarkers involved in thyroid cancer progression and their potential role in carcinogenic pathways.
Material And Methods:
Using whole transcriptome sequencing, lnc-MPEG1-1 was identified as a potential target. Expression levels of lnc-MPEG1-1 were analyzed in 43 PTC tissue samples and data from the Cancer Genome Atlas Thyroid Cancer (TCGA-THCA) cohort. Correlations between lnc-MPEG1-1 expression and clinical-pathological features were assessed. Functional assays, including cell proliferation, migration, and invasion, were conducted in vitro to investigate the biological role of lnc-MPEG1-1. Additionally, correlation analyses were performed to explore the relationship between lnc-MPEG1-1 expression and the B-Raf proto-oncogene, serine/threonine kinase V600E (BRAFV600E) mutation, a common genetic alteration in PTC.
Results:
lnc-MPEG1-1 was significantly upregulated in PTC tissues, with higher expression in BRAF-mutated samples. Knockdown of lnc-MPEG1-1 in PTC cell lines significantly reduced cell proliferation, migration, and invasion, indicating its role in promoting tumor aggressiveness. Correlation analyses revealed a strong association between lnc-MPEG1-1 expression and BRAF mutation-related genes. Pathway analysis suggested that lnc-MPEG1-1 is involved in oncogenic processes such as cell growth, epithelial-mesenchymal transition (EMT), and cell cycle regulation.
Conclusion:
lnc-MPEG1-1 is a novel lncRNA linked to BRAF mutations, promoting PTC progression. It holds potential as a prognostic biomarker and therapeutic target, particularly in BRAF-mutant PTC cases.
More Related Videos
Related Concept Videos
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
lncRNA - Long Non-coding RNAs
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

